Off-the-shelf CAR-T cell therapies for relapsed or refractory B-cell malignancies: latest update from ASH 2023 annual meeting
Abstract Currently, many off-the-shelf chimeric antigen receptor (CAR)-T cell products are under investigation for the treatment of relapsed or refractory (R/R) B-cell neoplasms. Compared with autologous CAR-T cell therapy, off-the-shelf universal CAR-T cell therapies have many potential benefits, s...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMC
2024-05-01
|
| Colección: | Journal of Hematology & Oncology |
| Acceso en línea: | https://doi.org/10.1186/s13045-024-01550-9 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|